Mass Tort Journal

  • Subscribe
  • Search
  • Menu
All Access
  • Home
  • Courtroom News
  • Litigation
  • Breaking News
  • Science & Medicine
  • Policy & Legislation
ALSO SEE

Does Off-Label Promotion Settlement Signal Change in FDA Policy?

Science & Medicine
Reuters | Aug 8, 2016

Consumer Reports: VW Diesel Buyback Not Enough

Consumer Reports also wants owners who opt for a fix to be able to change their mind and instead sell the car back to Volkswagen because the car may perform differently once a fix is performed.

Science & Medicine
Fierce Pharma | Aug 6, 2016
Jupiterimages-Pixland-Thinkstock

Big Pharma Ads Prominent During RNC, DNC Conventions

While the number of ads run on cable stations was similar between the two conventions, some of the brands differed. For instance, while Eli Lilly’s erectile dysfunction treatment Cialis had ads during both conventions' broadcasts, the ad for Pfizer’s ED competitor Viagra only ran during the Democratic event. AstraZeneca's ad for respiratory drug Symbicort also only saw airtime during the Democratic Convention.

Science & Medicine
Forbes | Aug 4, 2016

Study Concludes Lawyers Are Struggling with Substance Abuse and Depression

The American Bar Association (ABA) has partnered with Hazelden Betty Ford Foundation to study the rates of substance use and other mental health concerns among lawyers, and its findings were reported in the Journal of Addiction Medicine.

Science & Medicine
INC | Aug 4, 2016
Tesla-creative-commons

Consumer Reports: Tesla’s Autopilot Feature Misleading to Consumers

Consumer Reports said Thursday that Tesla Motors is misleading car owners by calling its semi-autonomous driving system "Autopilot," potentially giving them too much trust in their car's ability to drive itself.

Science & Medicine
Forbes | Aug 4, 2016
Robert-Byron-iStock-Thinkstock

FDA to Update Warnings on Labels for Fluoroquinolone Antibiotics

the FDA announced it is updating the labels of fluoroquinolones and warning doctors not to use fluoroquinolones in cases of acute bacterial sinusitis, bacterial exacerbation of chronic bronchitis, or uncomplicated urinary tract infections where drugs of other classes have not been tried first.

Science & Medicine
Legal Newsline | Jul 28, 2016
j4m3z-istock-thinkstock

Despite Lack of Evidence, Doctor Group Fears Lawyer Ads Will Cause People to Stop Taking Medicine

At its annual meeting last month, the American Medical Association adopted a policy to advocate for a requirement that attorney commercials that may cause patients to stop using necessary medications to include “appropriate” and “conspicuous” warnings.

Science & Medicine
Health News Review | Jul 18, 2016

Low T, Disease Mongering, and “Claims that Go Way Beyond the Evidence”

Sometimes journalists may take a look at a news release presenting new research on a widely used pharmaceutical treatment, but they don’t touch the story. This seems to have happened recently with two news releases making some claims that just maybe couldn’t pass the sniff test from journalists. One, from the Baylor College of Medicine, made an assertion that there is a “new medical condition identified for men suffering with low testosterone.” And a Tulane University School of Medicine news release on the same study asks: “Is hormone therapy for ‘low-T’ safe?” and concludes that such treatment is, indeed, “safe and beneficial.”

Science & Medicine
Reuters | Jul 15, 2016
Tesla-creative-commons

U.S. Regulators Looking at Tesla Autopilot Accidents

U.S. highway safety regulators have demanded that Tesla Motors Inc hand over detailed information about the design, operation and testing of its Autopilot technology following a May 7 fatal crash in which the system was in use.

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 12
  • Next Page »

© 2025 · Mass Tort Journal · All Rights Reserved

  • All Access
  • Courtroom News
  • Litigation
  • Policy & Legislation
  • Science & Medicine
  • Home
  • Breaking News
  • Litigation
  • Courtroom News
  • Science & Medicine
  • Policy & Legislation